ENOVNYQHealthcare·Medical Devices#32 in industry

Enovis Corporation

Reports in 10d· 2026-05-07

+14.4% · 90d

$24.54

+0.44 (+1.83%)

News

(1)

April 2026

Apr 6, 20263 weeks agoDEF 14AHealthcare

Enovis CORP — DEF 14A Filing

ENOVEnovis CORP

# 🧾 What This Document Is This is a **Definitive Proxy Statement (DEF 14A)** for Enovis Corporation. Think of it as an invitation and information packet for the company's **Annual Meeting of Stockholders**. It's a mandatory SEC filing that gives shareholders the details they need to vote on key is

Read summaryView on SEC EDGAR

Key Data

Market Cap$1.41B

Open$24.12

Prev Close$24.10

Day Range$24.24 – $25.14

52W Range$21.00 – $37.85

Volume644,910

P/E (TTM)—

EPS$-20.72

Dividend Yield—

Beta1.59

Profit Margin-52.69%

Revenue Growth2.60%

Price Target$44.73(+82.3%)

Next Earnings2026-05-07(10d)

Analyst Ratings

Strong Buy12 analysts

Buy 11Hold 1Sell 0

About

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Healthcare · Medical Devices

7,802 employees

www.enovis.com